These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33217679)

  • 41. Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.
    Narayan K; Khaw P; Bernshaw D; Mileshkin L; Kondalsamy-Chennakesavan S
    Int J Gynecol Cancer; 2012 Feb; 22(2):260-6. PubMed ID: 22080878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT?
    Harris KL; Maurer KA; Jarboe E; Werner TL; Gaffney D
    Gynecol Oncol; 2020 Jan; 156(1):243-250. PubMed ID: 31703813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer.
    Pol FJ; Zusterzeel PL; van Ham MA; Kuijpers DA; Bulten J; Massuger LF
    Gynecol Oncol; 2015 Sep; 138(3):579-84. PubMed ID: 26126782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of lymphovascular space invasion in endometrial cancer using the 55-gene signature selected by DNA microarray analysis.
    Watanabe T; Honma R; Kojima M; Nomura S; Furukawa S; Soeda S; Watanabe S; Fujimori K
    PLoS One; 2019; 14(9):e0223178. PubMed ID: 31557240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of Substantial LYMphovascular space invasion on sentinel lymph nodes status and recurrence in Endometrial Cancer patients: SLYM-EC a multicenter retrospective study.
    Buda A; Fruscio R; Mauro J; Imboden S; De Ponti E; Perrone E; Grassi T; Bruno V; Garcia-Pineda V; Taskin S; Restaino S; Siegenthaler F; Casarin J; Raimondo D; Capozzi VA; Vatansever D; Capasso I; Vizza E; Gungor M; Zapardiel I; Papadia A; Taskiran C; Fanfani F; Vizzielli G; Scambia G; Mueller M
    Eur J Surg Oncol; 2024 Dec; 50(12):108731. PubMed ID: 39418834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer.
    Peters EEM; Léon-Castillo A; Hogdall E; Boennelycke M; Smit VTHBM; Hogdall C; Creutzberg CL; Bosse T; Nout RA; Ørtoft G
    Int J Gynecol Pathol; 2022 May; 41(3):227-234. PubMed ID: 34392268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus.
    Sahin H; Meydanli MM; Sari ME; Kocaman E; Cuylan ZF; Yalcin I; Coban G; Özen Ö; Sirvan L; Güngör T; Ayhan A
    Taiwan J Obstet Gynecol; 2019 Jan; 58(1):82-89. PubMed ID: 30638487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors predicting recurrence in patients with stage IA endometrioid endometrial cancer: what is the importance of LVSI?
    Ureyen I; Karalok A; Turkmen O; Kimyon G; Akdas YR; Akyol A; Tasci T; Turan T
    Arch Gynecol Obstet; 2020 Mar; 301(3):737-744. PubMed ID: 31883046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymph Node Isolated Tumor Cells in Patients With Endometrial Cancer.
    Matsuo K; Chen L; Neuman MK; Klar M; Carlson JW; Roman LD; Wright JD
    JAMA Netw Open; 2024 Mar; 7(3):e240988. PubMed ID: 38497964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for paraaortic lymph node metastasis in endometrial cancer.
    Sari ME; Yalcin İ; Sahin H; Meydanli MM; Gungor T
    Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion.
    Bendifallah S; Canlorbe G; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Huguet F; Cortez A; Daraï E; Ballester M
    Br J Cancer; 2014 May; 110(11):2640-6. PubMed ID: 24809776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
    Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lower uterine segment involvement in lymphovascular space invasion and lymph node metastasis in endometrioid endometrial cancer.
    Cokmez H; Yilmaz A
    Ginekol Pol; 2019; 90(6):314-319. PubMed ID: 31276182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prognostic significance of lymphovascular space invasion in laparoscopic versus abdominal hysterectomy for endometrioid endometrial cancer.
    Dewdney SB; Jiao Z; Roma AA; Gao F; Rimel BJ; Thaker PH; Powell MA; Massad LS; Mutch DG; Zighelboim I
    Eur J Gynaecol Oncol; 2014; 35(1):7-10. PubMed ID: 24654453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of lymphovascular space invasion on a nomogram for predicting lymph node metastasis in endometrial cancer.
    Koskas M; Bassot K; Graesslin O; Aristizabal P; Barranger E; Clavel-Chapelon F; Haddad B; Luton D; Darai E; Rouzier R
    Gynecol Oncol; 2013 May; 129(2):292-7. PubMed ID: 23480871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphovascular space invasion and the treatment of stage I endometrioid endometrial cancer.
    van der Putten LJ; Geels YP; Ezendam NP; van der Putten HW; Snijders MP; van de Poll-Franse LV; Pijnenborg JM
    Int J Gynecol Cancer; 2015 Jan; 25(1):75-80. PubMed ID: 25356534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer.
    Peters EEM; Bartosch C; McCluggage WG; Genestie C; Lax SF; Nout R; Oosting J; Singh N; Smit HCSH; Smit VTHBM; Van de Vijver KK; Bosse T
    Histopathology; 2019 Jul; 75(1):128-136. PubMed ID: 31155736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.
    Matsuo K; Yoshino K; Hasegawa K; Murakami R; Ikeda Y; Adachi S; Hiramatsu K; Yokoyama T; Nishimura M; Sheridan TB; Enomoto T; Fujiwara K; Matsumura N; Konishi I; Fotopoulou C; Roman LD; Sood AK
    Gynecol Oncol; 2015 Feb; 136(2):198-204. PubMed ID: 25497604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parametrial spread is a prognostic factor in endometrial carcinoma.
    Sato R; Jobo T; Kuramoto H
    Eur J Gynaecol Oncol; 2003; 24(3-4):241-5. PubMed ID: 12807232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.